東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Hepatitis C virus treatment = highly...

Chayama, Kazuaki.

FindBook

Google Book

Amazon

博客來

Hepatitis C virus treatment = highly effective therapy with direct acting antivirals and associated viral resistance /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Hepatitis C virus treatment/ edited by Kazuaki Chayama.
其他題名:	highly effective therapy with direct acting antivirals and associated viral resistance /
其他作者:	Chayama, Kazuaki.
出版者:	Singapore :Springer Singapore : : 2017.,
面頁冊數:	vii, 75 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Hepatitis C - Treatment. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-2416-0
ISBN:	9789811024160

Hepatitis C virus treatment = highly effective therapy with direct acting antivirals and associated viral resistance /
Hepatitis C virus treatmenthighly effective therapy with direct acting antivirals and associated viral resistance /[electronic resource] :edited by Kazuaki Chayama. - Singapore :Springer Singapore :2017. - vii, 75 p. :ill., digital ;24 cm.

This book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication. These drugs have been developed to enhance the effect of interferon and ribavirin, as the resistant strains against each drug have been described both in vitro and in vivo and the existences of naturally occurring variants have been reported. However, since the combination of different classes of DAAs is sufficient to completely eradicate the virus without the need for interferon or ribavirin, the current treatment regimen does not include interferon. Ribavirin is used in combination with sofosbuvir, a potent polymerase inhibitor, to enhance its antiviral effects. Hepatitis C Virus Treatment offers readers a comprehensive guide to hepatitis C; describing the resistance profiles against these drugs and shedding light on the difficulties involved in DAA therapy and the direction of future treatments, it will equip doctors to understand the essentials of treating the disease. It also describes in detail new and innovative DAA treatments, the effects of the agents, and the characteristics of resistance, providing cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students.

ISBN: 9789811024160

Standard No.: 10.1007/978-981-10-2416-0doiSubjects--Topical Terms:

1566871
Hepatitis C
--Treatment.

LC Class. No.: RC848.H425

Dewey Class. No.: 616.3623

Hepatitis C virus treatment = highly effective therapy with direct acting antivirals and associated viral resistance /
LDR:02330nmm a2200301 a 4500 001 2088750
003 DE-He213
005 20161101043346.0
006 m d
007 cr nn 008maaau
008 171013s2017 si s 0 eng d
020 $a 9789811024160 $q (electronic bk.)
020 $a 9789811024153 $q (paper)
024 7 $a 10.1007/978-981-10-2416-0 $2 doi
035 $a 978-981-10-2416-0
040 $a GP $c GP
041 0 $a eng
050 4 $a RC848.H425
072 7 $a MJJ $2 bicssc
072 7 $a MED031000 $2 bisacsh
082 0 4 $a 616.3623 $2 23
090 $a RC848.H425 $b H529 2017
245 0 0 $a Hepatitis C virus treatment $h [electronic resource] : $b highly effective therapy with direct acting antivirals and associated viral resistance / $c edited by Kazuaki Chayama.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2017.
300 $a vii, 75 p. : $b ill., digital ; $c 24 cm.
520 $a This book introduces readers to Direct Acting Antiviral (DAAs) agents, newly developed drugs to treat chronic hepatitis C virus infection, which have an excellent anti-viral effect on virus replication. These drugs have been developed to enhance the effect of interferon and ribavirin, as the resistant strains against each drug have been described both in vitro and in vivo and the existences of naturally occurring variants have been reported. However, since the combination of different classes of DAAs is sufficient to completely eradicate the virus without the need for interferon or ribavirin, the current treatment regimen does not include interferon. Ribavirin is used in combination with sofosbuvir, a potent polymerase inhibitor, to enhance its antiviral effects. Hepatitis C Virus Treatment offers readers a comprehensive guide to hepatitis C; describing the resistance profiles against these drugs and shedding light on the difficulties involved in DAA therapy and the direction of future treatments, it will equip doctors to understand the essentials of treating the disease. It also describes in detail new and innovative DAA treatments, the effects of the agents, and the characteristics of resistance, providing cutting-edge information not only for hepatologists, but also for researchers, clinical residents, and medical students.
650 0 $a Hepatitis C $x Treatment. $3 1566871
650 0 $a Hepatitis C virus. $3 863347
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Hepatology. $3 894467
650 2 4 $a Virology. $3 642304
650 2 4 $a Drug Resistance. $3 836316
700 1 $a Chayama, Kazuaki. $3 3218772
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-2416-0
950 $a Medicine (Springer-11650)